Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Genome-wide analysis of androgen receptor binding and transcriptomic analysis in mesenchymal subsets during prostate development.

Nash C, Boufaied N, Badescu D, Wang YC, Paliouras M, Trifiro M, Ragoussis I, Thomson AA.

Dis Model Mech. 2019 Jul 25;12(7). pii: dmm039297. doi: 10.1242/dmm.039297.

2.

A Targeted Bivalent Androgen Receptor Binding Compound for Prostate Cancer Therapy.

Chowdhury S, Beitel LK, Lumbroso R, Purisima EO, Paliouras M, Trifiro M.

Horm Cancer. 2019 Feb;10(1):24-35. doi: 10.1007/s12672-018-0353-6. Epub 2018 Dec 18.

PMID:
30565014
3.

Enhanced radiosensitization of enzalutamide via schedule dependent administration to androgen-sensitive prostate cancer cells.

Ghashghaei M, Niazi TM, Heravi M, Bekerat H, Trifiro M, Paliouras M, Muanza T.

Prostate. 2018 Jan;78(1):64-75. doi: 10.1002/pros.23445. Epub 2017 Nov 14. Erratum in: Prostate. 2018 Feb;78(3):239.

PMID:
29134684
4.

Androgen Insensitivity Syndrome.

Gottlieb B, Trifiro MA.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019.
1999 Mar 24 [updated 2017 May 11].

5.

Real time plasmonic qPCR: how fast is ultra-fast? 30 cycles in 54 seconds.

Roche PJR, Najih M, Lee SS, Beitel LK, Carnevale ML, Paliouras M, Kirk AG, Trifiro MA.

Analyst. 2017 May 21;142(10):1746-1755. doi: 10.1039/c7an00304h. Epub 2017 Apr 26.

PMID:
28443837
6.

Network Analysis Reveals A Signaling Regulatory Loop in the PIK3CA-mutated Breast Cancer Predicting Survival Outcome.

McGee SR, Tibiche C, Trifiro M, Wang E.

Genomics Proteomics Bioinformatics. 2017 Apr;15(2):121-129. doi: 10.1016/j.gpb.2017.02.002. Epub 2017 Apr 7.

7.

Prostate-specific membrane antigen-directed nanoparticle targeting for extreme nearfield ablation of prostate cancer cells.

Lee SS, Roche PJ, Giannopoulos PN, Mitmaker EJ, Tamilia M, Paliouras M, Trifiro MA.

Tumour Biol. 2017 Mar;39(3):1010428317695943. doi: 10.1177/1010428317695943.

PMID:
28351335
8.

Correction: Engineering Multi-Walled Carbon Nanotube Therapeutic Bionanofluids to Selectively Target Papillary Thyroid Cancer Cells.

Dotan I, Roche PJ, Tamilia M, Paliouras M, Mitmaker EJ, Trifiro MA.

PLoS One. 2016 Jun 16;11(6):e0158022. doi: 10.1371/journal.pone.0158022. eCollection 2016.

9.

Engineering Multi-Walled Carbon Nanotube Therapeutic Bionanofluids to Selectively Target Papillary Thyroid Cancer Cells.

Dotan I, Roche PJ, Paliouras M, Mitmaker EJ, Trifiro MA.

PLoS One. 2016 Feb 22;11(2):e0149723. doi: 10.1371/journal.pone.0149723. eCollection 2016. Erratum in: PLoS One. 2016;11(6):e0158022.

10.

Characterization of the NPC1L1 gene and proteome from an exceptional responder to ezetimibe.

Schweitzer M, Makhoul S, Paliouras M, Beitel LK, Gottlieb B, Trifiro M, Chowdhury SF, Zaman NM, Wang E, Davis H, Chalifour LE.

Atherosclerosis. 2016 Mar;246:78-86. doi: 10.1016/j.atherosclerosis.2015.12.032. Epub 2015 Dec 24.

PMID:
26761771
11.

Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.

Gao S, Tibiche C, Zou J, Zaman N, Trifiro M, O'Connor-McCourt M, Wang E.

JAMA Oncol. 2016 Jan;2(1):37-45. doi: 10.1001/jamaoncol.2015.3413.

PMID:
26502222
12.

Proteomic-coupled-network analysis of T877A-androgen receptor interactomes can predict clinical prostate cancer outcomes between White (non-Hispanic) and African-American groups.

Zaman N, Giannopoulos PN, Chowdhury S, Bonneil E, Thibault P, Wang E, Trifiro M, Paliouras M.

PLoS One. 2014 Nov 19;9(11):e113190. doi: 10.1371/journal.pone.0113190. eCollection 2014.

13.
14.

Coexistence of malignant struma ovarii and cervical papillary thyroid carcinoma.

Leong A, Roche PJ, Paliouras M, Rochon L, Trifiro M, Tamilia M.

J Clin Endocrinol Metab. 2013 Dec;98(12):4599-605. doi: 10.1210/jc.2013-1782. Epub 2013 Nov 11.

PMID:
24217901
15.

Signaling network assessment of mutations and copy number variations predict breast cancer subtype-specific drug targets.

Zaman N, Li L, Jaramillo ML, Sun Z, Tibiche C, Banville M, Collins C, Trifiro M, Paliouras M, Nantel A, O'Connor-McCourt M, Wang E.

Cell Rep. 2013 Oct 17;5(1):216-23. doi: 10.1016/j.celrep.2013.08.028. Epub 2013 Sep 26.

16.

Cancer systems biology in the genome sequencing era: part 2, evolutionary dynamics of tumor clonal networks and drug resistance.

Wang E, Zou J, Zaman N, Beitel LK, Trifiro M, Paliouras M.

Semin Cancer Biol. 2013 Aug;23(4):286-92. doi: 10.1016/j.semcancer.2013.06.001. Epub 2013 Jun 18. Review.

PMID:
23792107
17.

Cancer systems biology in the genome sequencing era: part 1, dissecting and modeling of tumor clones and their networks.

Wang E, Zou J, Zaman N, Beitel LK, Trifiro M, Paliouras M.

Semin Cancer Biol. 2013 Aug;23(4):279-85. doi: 10.1016/j.semcancer.2013.06.002. Epub 2013 Jun 19. Review.

PMID:
23791722
18.

Mechanisms mediating spinal and bulbar muscular atrophy: investigations into polyglutamine-expanded androgen receptor function and dysfunction.

Beitel LK, Alvarado C, Mokhtar S, Paliouras M, Trifiro M.

Front Neurol. 2013 May 15;4:53. doi: 10.3389/fneur.2013.00053. eCollection 2013.

19.

Making sense of intratumor genetic heterogeneity: altered frequency of androgen receptor CAG repeat length variants in breast cancer tissues.

Gottlieb B, Alvarado C, Wang C, Gharizadeh B, Babrzadeh F, Richards B, Batist G, Basik M, Beitel LK, Trifiro M.

Hum Mutat. 2013 Apr;34(4):610-8. doi: 10.1002/humu.22287. Epub 2013 Mar 8.

PMID:
23377847
20.

Demonstration of a plasmonic thermocycler for the amplification of human androgen receptor DNA.

Roche PJ, Beitel LK, Khan R, Lumbroso R, Najih M, Cheung MC, Thiemann J, Veerasubramanian V, Trifiro M, Chodavarapu VP, Kirk AG.

Analyst. 2012 Oct 7;137(19):4475-81. doi: 10.1039/c2an35692a.

PMID:
22871797
21.

The androgen receptor gene mutations database: 2012 update.

Gottlieb B, Beitel LK, Nadarajah A, Paliouras M, Trifiro M.

Hum Mutat. 2012 May;33(5):887-94. doi: 10.1002/humu.22046. Epub 2012 Mar 13.

PMID:
22334387
22.

Altered redox homeostasis in human diabetes saliva.

Su H, Velly AM, Salah MH, Benarroch M, Trifiro M, Schipper HM, Gornitsky M.

J Oral Pathol Med. 2012 Mar;41(3):235-41. doi: 10.1111/j.1600-0714.2011.01092.x. Epub 2011 Nov 14.

PMID:
22077396
23.

Dynamic rewiring of the androgen receptor protein interaction network correlates with prostate cancer clinical outcomes.

Paliouras M, Zaman N, Lumbroso R, Kapogeorgakis L, Beitel LK, Wang E, Trifiro M.

Integr Biol (Camb). 2011 Oct;3(10):1020-32. doi: 10.1039/c1ib00038a. Epub 2011 Sep 7.

PMID:
21901193
24.

Handheld impedance biosensor system using engineered proteinaceous receptors.

Ghafar-Zadeh E, Chowdhury SF, Aliakbar A, Chodavarapu V, Lumbroso R, Beitel LK, Sawan M, Trifiro M.

Biomed Microdevices. 2010 Dec;12(6):967-75. doi: 10.1007/s10544-010-9451-0. Erratum in: Biomed Microdevices. 2010 Dec;12(6):1107. Lambrose, Rosemond [corrected to Lumbroso, Rose]; Beital, Lenord [corrected to Beitel, Lenore K].

PMID:
20652414
25.

Selection and mutation in the "new" genetics: an emerging hypothesis.

Gottlieb B, Beitel LK, Alvarado C, Trifiro MA.

Hum Genet. 2010 Mar;127(5):491-501. doi: 10.1007/s00439-010-0792-9. Epub 2010 Jan 23. Review.

PMID:
20099069
26.

The role of sentinel lymph node biopsy in differentiated thyroid carcinoma.

Anand SM, Gologan O, Rochon L, Tamilia M, How J, Hier MP, Black MJ, Richardson K, Hakami HA, Marzouki HZ, Trifiro M, Tabah R, Payne RJ.

Arch Otolaryngol Head Neck Surg. 2009 Dec;135(12):1199-204. doi: 10.1001/archoto.2009.190.

PMID:
20026816
27.

Serum sex hormones and the 20-year risk of lower urinary tract symptoms in community-dwelling older men.

Trifiro MD, Parsons JK, Palazzi-Churas K, Bergstrom J, Lakin C, Barrett-Connor E.

BJU Int. 2010 Jun;105(11):1554-9. doi: 10.1111/j.1464-410X.2009.09090.x. Epub 2009 Dec 7.

28.

Molecular studies of a patient with complete androgen insensitivity and a 47,XXY karyotype.

Girardin CM, Deal C, Lemyre E, Paquette J, Lumbroso R, Beitel LK, Trifiro MA, Van Vliet G.

J Pediatr. 2009 Sep;155(3):439-43. doi: 10.1016/j.jpeds.2009.02.052.

PMID:
19732585
29.

Somatic mosaicism of androgen receptor CAG repeats in colorectal carcinoma epithelial cells from men.

Di Fabio F, Alvarado C, Gologan A, Youssef E, Voda L, Mitmaker E, Beitel LK, Gordon PH, Trifiro M.

J Surg Res. 2009 Jun 1;154(1):38-44. doi: 10.1016/j.jss.2008.05.013. Epub 2008 Jun 11.

PMID:
19062046
30.

Isolation of human proteasomes and putative proteasome-interacting proteins using a novel affinity chromatography method.

Scanlon TC, Gottlieb B, Durcan TM, Fon EA, Beitel LK, Trifiro MA.

Exp Cell Res. 2009 Jan 15;315(2):176-89. doi: 10.1016/j.yexcr.2008.10.027. Epub 2008 Nov 5.

PMID:
19013454
31.

An investigation into CAG repeat length variation and N/C terminal interactions in the T877A mutant androgen receptor found in prostate cancer.

Southwell J, Chowdhury SF, Gottlieb B, Beitel LK, Lumbroso R, Purisima EO, Trifiro M.

J Steroid Biochem Mol Biol. 2008 Jul;111(1-2):138-46. doi: 10.1016/j.jsbmb.2008.04.009. Epub 2008 Jun 20.

PMID:
18619542
32.

Microsatellite instability in benign and malignant thyroid neoplasms.

Mitmaker E, Alvarado C, Bégin LR, Trifiro M.

J Surg Res. 2008 Nov;150(1):40-8. doi: 10.1016/j.jss.2007.12.760. Epub 2008 Jan 11.

PMID:
18243241
33.

Underexpression of mineralocorticoid receptor in colorectal carcinomas and association with VEGFR-2 overexpression.

Di Fabio F, Alvarado C, Majdan A, Gologan A, Voda L, Mitmaker E, Beitel LK, Gordon PH, Trifiro M.

J Gastrointest Surg. 2007 Nov;11(11):1521-8. Epub 2007 Aug 17.

PMID:
17703341
34.

Will knowledge of human genome variation result in changing cancer paradigms?

Gottlieb B, Beitel LK, Trifiro M.

Bioessays. 2007 Jul;29(7):678-85. Review.

PMID:
17563087
35.

Androgen receptor CAG repeat length contraction in diseased and non-diseased prostatic tissues.

Sircar K, Gottlieb B, Alvarado C, Aprikian A, Beitel LK, Alam-Fahmy M, Begin L, Trifiro M.

Prostate Cancer Prostatic Dis. 2007;10(4):360-8. Epub 2007 Apr 17.

PMID:
17440439
36.

Impaired helix 12 dynamics due to proline 892 substitutions in the androgen receptor are associated with complete androgen insensitivity.

Elhaji YA, Stoica I, Dennis S, Purisima EO, Lumbroso R, Beitel LK, Trifiro MA.

Hum Mol Genet. 2006 Mar 15;15(6):921-31. Epub 2006 Jan 31. Erratum in: Hum Mol Genet. 2006 May 1;15(9):1561. Lumbroso, Rose [added]; Beitel, Lenore K [added].

PMID:
16449235
37.

Somatic mosaicism and cancer: a micro-genetic examination into the role of the androgen receptor gene in prostate cancer.

Alvarado C, Beitel LK, Sircar K, Aprikian A, Trifiro M, Gottlieb B.

Cancer Res. 2005 Sep 15;65(18):8514-8.

38.
39.

Molecular pathology of the androgen receptor in male (in)fertility.

Gottlieb B, Lombroso R, Beitel LK, Trifiro MA.

Reprod Biomed Online. 2005 Jan;10(1):42-8. Review.

PMID:
15705293
40.

Nuclear receptors and disease: androgen receptor.

Gottlieb B, Beitel LK, Wu J, Elhaji YA, Trifiro M.

Essays Biochem. 2004;40:121-36. Review.

PMID:
15242343
41.

Hormonal manipulation of benign metastasizing leiomyomas: report of two cases and review of the literature.

Rivera JA, Christopoulos S, Small D, Trifiro M.

J Clin Endocrinol Metab. 2004 Jul;89(7):3183-8. Review.

PMID:
15240591
42.

Estrogen and androgen protection of human neurons against intracellular amyloid beta1-42 toxicity through heat shock protein 70.

Zhang Y, Champagne N, Beitel LK, Goodyer CG, Trifiro M, LeBlanc A.

J Neurosci. 2004 Jun 9;24(23):5315-21.

43.

The androgen receptor gene mutations database (ARDB): 2004 update.

Gottlieb B, Beitel LK, Wu JH, Trifiro M.

Hum Mutat. 2004 Jun;23(6):527-33. Erratum in: Hum Mutat. 2004 Jul;24(1):102.

PMID:
15146455
44.

An examination of how different mutations at arginine 855 of the androgen receptor result in different androgen insensitivity phenotypes.

Elhaji YA, Wu JH, Gottlieb B, Beitel LK, Alvarado C, Batist G, Trifiro MA.

Mol Endocrinol. 2004 Aug;18(8):1876-86. Epub 2004 Apr 29.

PMID:
15118070
45.

Characterization of intracellular aggregates using fluorescently-tagged polyglutamine-expanded androgen receptor.

Panet-Raymond V, Gottlieb B, Beitel LK, Schipper H, Timiansky M, Pinsky L, Trifiro MA.

Neurotox Res. 2001 Jul;3(3):259-75.

PMID:
15111251
46.

Bridging structural biology and genetics by computational methods: an investigation into how the R774C mutation in the AR gene can result in complete androgen insensitivity syndrome.

Wu JH, Gottlieb B, Batist G, Sulea T, Purisima EO, Beitel LK, Trifiro M.

Hum Mutat. 2003 Dec;22(6):465-75. Erratum in: Hum Mutat. 2004 Apr;23(4):394.

PMID:
14635106
47.

Transglutaminase potentiates ligand-dependent proteasome dysfunction induced by polyglutamine-expanded androgen receptor.

Mandrusiak LM, Beitel LK, Wang X, Scanlon TC, Chevalier-Larsen E, Merry DE, Trifiro MA.

Hum Mol Genet. 2003 Jul 1;12(13):1497-506.

PMID:
12812978
48.

The use of androgen receptor amino/carboxyl-terminal interaction assays to investigate androgen receptor gene mutations in subjects with varying degrees of androgen insensitivity.

Ghali SA, Gottlieb B, Lumbroso R, Beitel LK, Elhaji Y, Wu J, Pinsky L, Trifiro MA.

J Clin Endocrinol Metab. 2003 May;88(5):2185-93.

PMID:
12727974
49.

A functional analysis of disease-associated mutations in the androgen receptor gene.

Mooney SD, Klein TE, Altman RB, Trifiro MA, Gottlieb B.

Nucleic Acids Res. 2003 Apr 15;31(8):e42.

50.

Cloning and characterization of an androgen receptor N-terminal-interacting protein with ubiquitin-protein ligase activity.

Beitel LK, Elhaji YA, Lumbroso R, Wing SS, Panet-Raymond V, Gottlieb B, Pinsky L, Trifiro MA.

J Mol Endocrinol. 2002 Aug;29(1):41-60.

PMID:
12200228

Supplemental Content

Loading ...
Support Center